DR.ANEESH GHOSH M S
MD(Gen Med), DNB (Endrocrinology)
Dr. Aneesh Ghosh M S, Senior Consultant, (Chief of Endocrinology and metabolism) is a highly accomplished and academically brilliant Endocrinologist. He has more than 15 years of experience in the field of Diabetes and Endocrinology and is an avid researcher having more than 60 presentations and publications. He is a designated faculty to ESICON, RSSDI, API and IMA, and has given more than 250 lectures and presented his original research work in prestigious National and International conferences.
OP days : 9.30 am - 2.00 pm(Monday - Saturday)
Qualification & Higher Training
DNB (Endocrinology) training - Amrita Institute of Medical Sciences, Kochi
MD (General Medicine) - Manipal Academy of Higher Education, Karnataka
MBBS, Manipal Academy of Higher Education, Karnataka
Previous Experience
Senior Resident, Amrita Institute of Medical Sciences, Kochi
Professional Membership
Life Member, Indian Medical Association
Member, Endocrine Society of India (ESI), American Diabetes Association (ADA), Research Society for the study of Diabetes in India (RSSDI).
Scientific Committee Secretary: ESICON 2017, PACE MASTER CLASS 2020
Executive Committee Member: PACE
Vice President: Travancore Endocrine Associates
Papers presented in
- US ENDO conference in 2019 and 2021
- American Thyroid Association (ATA) annual conference in 2019
- International Diabetes Federation (IDF) conference in 2019
- American association of clinical Endocrinologists (AACE), Annual conference in 2018,2019 and 2020
- Endocrine Society of India (ESI), Annual conference in 2016 and 2019
Recent Publications 2019-2021
- The manuscript of the study “The prevalence of Vitiligo and the role of thyroid antibody among patients with type 2 diabetes mellitus” has been accepted published in the Indian Journal of Endocrinology andMetabolism¦ Volume 23 ¦ Issue (Supplement) ¦ November 2019
https://www.ijem.in/text.asp?2019/23/7/5/271346
- Published “A Case of Euglycemic Diabetic Keto Acidosis in a type 2 diabetic patient receiving Empagliflozin therapy along with basal insulin”- first case report of Empagliflozin in the serious adverse event reporting category from Kerala - Indian Journal of Endocrinology and Metabolism ¦ Volume 23 ¦ Issue 4 ¦ July-August 2019
https://www.ijem.in/text.asp?2019/23/4/500/268499
- Published the original work, titled “Improved Clinical Outcomes With Dulaglutide as Add-on Medication to Oral Antidiabetic Drugs With or Without Insulin in 85 South Indian Patients With Type 2 Diabetes Mellitus”, in the Current Diabetes Reveiws 16;5:490-496.
https://www.eurekaselect.com/176371/article
- The original work titled “Extra glycaemic benefits of Remogliflozin in patients with metabolic syndrome and type 2 diabetes mellitus: A retrospective real-world study” has been published in Journal of The Diabetes and Endocrine Practice 2020 3; 3: 86-120
https://www.jdeponline.com/text.asp?2020/3/3/86/311935
- The original work titled “Correlation of the Diagnostic Performance of Ultrasonography with Fine: Needle aspiration Cytology in Thyroid Nodules: A Single Centre Retrospective Study” in the category chosen of “Thyroid Disorders” has been published in Journal of The Diabetes and Endocrine Practice 2020 3; 3: 86-120.
https://www.jdeponline.com/text.asp?2020/3/3/86/311935
Books Published - 2021
- Written a book for the public diabetic patients titled “Living with Diabetes: A Complete Patient Wellness Guide".This guide, a patient centered and peer reviewed journal, is an attempt to facilitate diabetes self-care. This has been accepted by DC Booksfor publications. The print will be available early next year across the country.
- Contributed a chapter in a book titled “Nutritional Management of Diabetes during Ramadan” published by Knowledge Bridge Pvt., Ltd.
Areas of Expertise
His fields of expertise include Insulin pumptherapy in children with type 1 Diabetes Mellitus, management of thyroid disorders, adrenal disorders and Obesity management
0471 2579900, 6609900 
ahri@ahri.in
Doctor
